Many sweeteners marketed as “diabetic-friendly,” such as Equal and Sweet’N Low, contain maltodextrin—a filler with a glycaemic index (GI) of 110, which is higher than regular sugar. Despite this, these products are often advertised as safe for people with diabetes, potentially misleading consumers and putting their health at risk.

Maltodextrin can cause a significant spike in blood sugar levels, which is especially concerning for diabetics who regularly consume these sweeteners. The inclusion of such high-GI ingredients in products marketed to diabetics goes largely unnoticed, making it difficult for consumers to manage their blood sugar levels effectively.

Potential Side Effects of Excessive Maltodextrin Intake

 • Blood Sugar Spikes

 • Gut Health Issues

 • Increased Risk of Obesity

 • Potential Allergic Reactions

 • Possible Link to Chronic Disease

We are calling on the Australian Competition and Consumer Commission (ACCC) to investigate these misleading marketing practices and ensure that sweeteners containing maltodextrin are accurately labelled, with clearer warnings regarding potential risks for diabetics. Let’s protect the health of millions of Australians managing diabetes by holding manufacturers accountable for their claims.

Sign this petition to demand safer, more transparent sweeteners for people with diabetes.